Albany, NY -- (SBWIRE) -- 10/17/2019 -- Lactose Intolerance Market Insights, Epidemiology and Market Forecast-2028

1. Lactose Intolerance total prevalent cases in the 7MM were found to be 226,677,104 in 2017.
2. In 2017, the diagnosed prevalent population of Lactose Intolerance in 7MM was found to be 154,752,209 cases.
3. There were total 22,293,305 mild and 9,554,274 moderate to severe cases of Lactose Intolerance in 2017 in the United States.
4. In 2017, there were 84,726,469 Lactose Intolerance prevalent cases in Japan. Out of which, accounts for approximately 39.0% of total diagnosed cases, for Lactose Intolerance, in the 7MM countries. In 2017, Japan witnessed 59,650,499 cases for Lactose Intolerance.

(Albany, US) DelveInsight launched a new report on Lactose Intolerance Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. Lactose Intolerance market report covers a descriptive overview and comprehensive insight of the Lactose Intolerance epidemiology and Lactose Intolerance market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Lactose Intolerance market report provides insights on the current and emerging therapies.
3. Lactose Intolerance market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Lactose Intolerance market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Lactose Intolerance market.
Request for sample pages

"There were total 154,752,209 severity-specific (Mild, Moderate to Severe) cases of Lactose Intolerance in 2017 in 7MM."

Lactose Intolerance market size in the 7MM is USD 9,688.54 million in 2017, which increases during the study period (2017-2028). The United States accounts for the Lactose Intolerance highest market size in comparison to the other major markets i.e., EU5 countries (the United Kingdom, Germany, Italy, France, and Spain), and Japan. Among the EU5 countries, Italy had the Lactose Intolerance highest market size in 2017, while Germany had the lowest Lactose Intolerance market size.
The management of lactose Intolerance consists of avoidance of milk products, dietary supplements, and use of an enzyme (lactase) containing pills.
At present there is no pharmacological therapy approved by the US Food and Drug Administration (FDA), and the current therapeutic landscape depends primarily on dietary supplements (which includes, lactose-free milk, lactose free yogurt, lactose free cheese etc.), lactase supplements and to avoid the dietary or lactose products.
The current therapeutic landscape of Lactose Intolerance in the US is primarily driven by supportive management practices, such as dietary supplements and lactase enzyme supplements. Some patients are recommended to limit the consumption of lactose, while others require to avoid lactose completely. Of the currently prescribed management options, dietary supplements occupy majority of the share, followed by lactase supplements.
To summarize the current treatment practices, the Lactose Intolerance market is widely described on the basis of two of classes of products that are recommended to patients with lactose intolerance, namely dietary supplements and lactase supplements. Overall, the increasing prevalence of the disease along with the promising emerging pipeline therapy is expected to fuel the Lactose Intolerance market size during the forecasted period of 2019–2028.

The launch of the emerging therapies is expected to significantly impact Lactose Intolerance treatment scenario in the upcoming years:-
Drugs covered
1. RP?G28
And many others

The key players in Lactose Intolerance market are:
1. Ritter Pharmaceuticals
And many others

Table of contents

1. Key Insights
2. Lactose Intolerance Market Overview at a Glance
3. Lactose Intolerance Disease Background and Overview
4. Lactose Intolerance Epidemiology and Patient Population
5. Country Wise Lactose Intolerance Epidemiology
5.1. United States Epidemiology
5.2. EU-5 Epidemiology
5.2.1. Germany
5.2.2. France
5.2.3. Italy
5.2.4. Spain
5.2.5. United Kingdom
5.3. Japan Epidemiology
6. Lactose Intolerance Treatment and Management
7. Unmet Needs
8. Lactose Intolerance Emerging Drugs
8.1. RP?G28: Ritter Pharmaceuticals
9. Lactose Intolerance 7 Major Market Analysis
10. Lactose Intolerance Market Outlook The United States
10.1.United States Market Size
11. Market Outlook: Europe
11.1.Germany
11.2. France
11.3. Italy
11.4. Spain
11.5.United Kingdom
12. Market Outlook: Japan
13. Market Drivers
14. Market Barriers
15. Appendix
16. DelveInsight Capabilities
17. Disclaimer
18. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight